Karen Brown
Conseiller Juridique Général chez PRIME MEDICINE, INC.
Profil
Karen Brown is currently the Senior VP-Intellectual Property & Legal Affairs at Prime Medicine, Inc. Previously, she held the position of Chief Intellectual Property Counsel at Ironwood Pharmaceuticals, Inc. and Senior Vice President-IP & Legal Affairs at Obsidian Therapeutics, Inc. Dr. Brown has a doctorate degree from Boston University, an undergraduate degree from Princeton University, and a graduate degree from Fordham University School of Law.
Postes actifs de Karen Brown
| Sociétés | Poste | Début |
|---|---|---|
| PRIME MEDICINE, INC. | Conseiller Juridique Général | - |
Anciens postes connus de Karen Brown
| Sociétés | Poste | Fin |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Conseiller Juridique Général | - |
Formation de Karen Brown
| Princeton University | Undergraduate Degree |
| Boston University | Doctorate Degree |
| Fordham University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PRIME MEDICINE, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
